CN Stock MarketDetailed Quotes

300966 Hubei Goto Biopharm

Watchlist
  • 18.33
  • -0.59-3.12%
Market Closed Nov 15 15:00 CST
2.11BMarket Cap-151487P/E (TTM)

About Hubei Goto Biopharm Company

The company's main products are starting materials, intermediates and raw materials required for steroidal drug production. It is an important enterprise in the field of starting materials for steroidal drugs. Relying on the advantages of starting material products, it has formed a relatively complete industrial chain for cortical hormones, sex hormones, and progesterone series intermediates, and is an important R&D and production base for steroidal drug intermediates in China. The company mainly engages in R&D, production and sales of steroidal pharmaceutical raw materials. The company's main products are starting materials, intermediates and raw materials required for the production of steroidal drugs. Corporate honors include the Provincial Science and Technology Progress Second Prize Certificate, Shiyan Innovation and Entrepreneurship Strategy Team, and the High Enterprise Certificate.

Company Profile

Short Name-A共同药业
Symbol-A300966
Company NameHubei Goto Biopharm Co.,Ltd.
Listing DateApr 9, 2021
Issue Price8.24
Shares Offered29.00M share(s)
FoundedMay 15, 2006
Legal Representativezubin xi
General Managerzubin xi
Secretarywenjing chen
Accounting FirmDaxin Certified Public Accountants (Special General Partnership)
Securities Representativeying wan
Legal CounselBeijing Zhonglun (Wuhan) Law Firm
Employees163
Phone0710-3523126
Office Address33rd Floor, Building 1, World Financial City, Jiangshan South Road, Wolong Avenue, Fancheng District, Xiangyang City, Hubei Province
Zip Code441057
Registered AddressGroup 1, Gaokeng, Xiaohe Town, Yicheng City, Xiangyang City, Hubei
Fax0710-3523126
Emailboard@gotopharm.com
Business License420684000000665
BusinessPharmaceutical science and technology development and technical services; production and sale of pharmaceutical raw materials and intermediates (excluding the production and sale of medical devices and hazardous chemicals prone to drug production); import and export of goods or technology (other than goods or technology restricted or prohibited by the country); where laws, administrative regulations, or decisions of the State Council allow operation without a prescribed license, the enterprise independently selects a business project to carry out the operation. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • zubin xi
  • Chairman, directors, general manager, Director of R&D, Chairman of the Strategy Committee, Nomination Committee Members
  • 729.30K
  • xiangdong liu
  • Directors, Chief Financial Officer
  • 361.60K
  • minglei li
  • Directors, Deputy General Manager, Strategy Committee Member
  • --
  • xueming wang
  • Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee
  • 244.00K
  • deliang he
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Strategy Committee Member
  • --
  • fei qi
  • Independent Directors, Chairman of the Nomination Committee, Audit Committee Member, Member of the Remuneration and Assessment Committee
  • --
  • ziwu long
  • Independent Directors, Chairman of the Audit Committee, Nomination Committee Members
  • --
  • wenjing chen
  • Board Secretary, Deputy General Manager
  • 546.90K
  • ying wan
  • Securities Affairs Representative
  • --
  • jianjun jiang
  • Chairman of the Supervisory Board, Auditors
  • --
  • huan cao
  • Auditors
  • --
  • wei ren
  • Employee Supervisors
  • 133.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data